The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Home
>
Delaware
>
Wilmington
>
Incyte Corporation

Incyte Corporation

  • Contact Person: Paul Saccarelli
  • Contact Phone: 302-498-7034
  • Contact Email: psaccarelli@incyte.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Manufacturer of Goods
  • Industries Served: Pharmaceutical Preparation Manufacturing
  • Product Areas: DRUGS AND BIOLOGICALS

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $9,940 - Wednesday the 1st of August 2012
    Veterans Affairs Department
    243-NETWORK CONTRACTING OFFICE 03
    JAKAFI 20 MG TABS 60'S
  • $5,330 - Monday the 27th of February 2012
    Veterans Affairs Department
    243-NETWORK CONTRACTING OFFICE 03
    MEDICATION
  • $5,240 - Monday the 16th of April 2012
    Veterans Affairs Department
    261-NETWORK CONTRACT OFFICE 21
    JAFAFI 15MG #60/BOTTLE
  • $5,240 - Monday the 16th of April 2012
    Veterans Affairs Department
    261-NETWORK CONTRACT OFFICE 21
    JAKAFI 10MG
  • $5,240 - Tuesday the 24th of July 2012
    Veterans Affairs Department
    546-MIAMI
    JAKAFI 10MG TABS
  • $5,240 - Friday the 18th of May 2012
    Veterans Affairs Department
    520-BILOXI
    JAKAFI 15MG (1 BT)
  • $5,240 - Friday the 1st of June 2012
    Veterans Affairs Department
    580-HOUSTON
    JAKAFI
  • $5,240 - Wednesday the 8th of February 2012
    Veterans Affairs Department
    243-NETWORK CONTRACTING OFFICE 03
    JAKAFI 20MG TABLETS
  • $5,240 - Wednesday the 18th of April 2012
    National Institutes Of Health
    NIH, CC, OD OCOO OA OFC ACQUISITIONS
    INCYTE GENOMICS INC:1110177
  • $5,240 - Monday the 5th of March 2012
    Veterans Affairs Department
    243-NETWORK CONTRACTING OFFICE 03
    JAKAFI (RUXOLITINIB) 15MG 60/BT

© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.